scPharmaceuticals Inc. (SCPH): Price and Financial Metrics


scPharmaceuticals Inc. (SCPH): $4.80

0.12 (+2.56%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SCPH Stock Price Chart Interactive Chart >

Price chart for SCPH

SCPH Price/Volume Stats

Current price $4.80 52-week high $7.28
Prev. close $4.68 52-week low $3.48
Day low $4.80 Volume 2,000
Day high $4.95 Avg. volume 56,522
50-day MA $4.78 Dividend yield N/A
200-day MA $5.22 Market Cap 131.38M

scPharmaceuticals Inc. (SCPH) Company Bio


scPharmaceuticals Inc. engages in the development and commercialization of transformative pharmaceutical products. The company’s under development products are for heart failure and infectious diseases that include Furoscix that is for treatment of worsening or decompensated heart failure outside of the inpatient setting. scPharmaceuticals Inc. formerly known as scPharmaceuticals LLC. and changed its name to scPharmaceuticals Inc. in March 2014. The company was founded 2013 and is based in Burlington, Massachusetts.


SCPH Latest News Stream


Event/Time News Detail
Loading, please wait...

SCPH Latest Social Stream


Loading social stream, please wait...

View Full SCPH Social Stream

Latest SCPH News From Around the Web

Below are the latest news stories about scPharmaceuticals Inc that investors may wish to consider to help them evaluate SCPH as an investment opportunity.

Here's What scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shareholder Ownership Structure Looks Like

If you want to know who really controls scPharmaceuticals Inc. ( NASDAQ:SCPH ), then you'll have to look at the makeup...

Yahoo | February 21, 2022

scPharmaceuticals to Present at the 42nd Annual Cowen Healthcare Conference

BURLINGTON, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 42 nd Annual Cowen Healthcare Conference on Tuesday, March 8 at 1:30pm EST.

GlobeNewswire | February 16, 2022

scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

BURLINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17 at 4:20pm EDT. A live webcast of the presentation can

Yahoo | February 3, 2022

Analysts Offer Insights on Healthcare Companies: scPharmaceuticals (SCPH), uniQure (QURE) and Cullinan Management (CGEM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on scPharmaceuticals (SCPH – Research Report), uniQure (QURE – Research Report) and Cullinan Management (CGEM – Research Report). scPharmaceuticals (SCPH) In a report issued on December 16, Roanna Ruiz from Leerink Partners maintained a Hold rating on scPharmaceuticals, with a price target of $6.00. The company's shares closed last Friday at $4.85. According to TipRanks.

Brian Anderson on TipRanks | December 20, 2021

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

BURLINGTON, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, will participate virtually in two upcoming investor conferences. Events: 11th Annual LifeSci Partners Corporate Access Event 2022Wednesday, January 5 – Friday, Jan

Yahoo | December 20, 2021

Read More 'SCPH' Stories Here

SCPH Price Returns

1-mo N/A
3-mo -15.49%
6-mo -4.38%
1-year -15.19%
3-year 50.47%
5-year N/A
YTD -4.38%
2021 -5.10%
2020 -6.54%
2019 50.53%
2018 -68.90%
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.989 seconds.